Amanta Healthcare IPO
Amanta Healthcare IPO — date, price band, lot size & details 2025
Amanta Healthcare listed on 9 Sep 2025 at ₹135, 7.1% above the ₹126 issue price.
Amanta Healthcare makes sterile liquid products in plastic containers using Aseptic Blow-Fill-Seal and Injection Stretch Blow Moulding technology. Its products include IV fluids, ophthalmic solutions and respiratory care products.
Stock price
Amanta Healthcare is listed — here is the live share price.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Timetable
Key dates from opening to listing. Today is 10 November.
- Open 01 Sep 2025
- Close 03 Sep 2025
- Allotment 04 Sep 2025
- Refund/credit 08 Sep 2025
- Listing 09 Sep 2025
Issue summary
The terms of the offer, as filed.
| IPO Dates | 1 to 3 Sep, 2025 |
|---|---|
| Price Band | ₹120 – ₹126 |
| Face Value | ₹10 |
| Lot Size | 119 Shares |
| Issue Size | ₹126 Cr |
| Sale Type | Fresh capital only |
| Listing On | BSE, NSE |
| Registrar | MUFG Intime India Private Limited |
| Min Investment | ₹ 14,994 |
Share of the offer set aside for each investor category, as stated in the offer document.
What will it cost me?
Bidding is in multiples of 119 shares at the ₹126 cut-off. Drag to size your application.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 119 | ₹14,994 |
| Retail (max) | 13 | 1,547 | ₹1,94,922 |
| S-HNI (min) | 14 | 1,666 | ₹2,09,916 |
| S-HNI (max) | 66 | 7,854 | ₹9,89,604 |
| B-HNI (min) | 67 | 7,973 | ₹10,04,598 |
Strengths & risks
Drawn from the offer document — the case for and against, side by side.
Strengths · 5
- 01Profit after tax improved from a loss of Rs 2.11 crore in FY2023 to a profit of Rs 10.50 crore in FY2025.
- 02The EBITDA margin was 22.11%, as per the figures at the source.
- 03The whole Rs 126 crore issue was fresh capital for the company.
- 04Rs 100.13 crore of the proceeds was for capacity projects.
- 05Total borrowing fell from Rs 215.66 crore on 31 March 2023 to Rs 195.00 crore on 31 March 2025.
Risks · 7
- 01The P/E was 46.59 at the upper band of Rs 126, based on post-issue EPS of Rs 2.70.
- 02Total borrowing of Rs 195.00 crore on 31 March 2025 was about twice net worth of Rs 96.39 crore.
- 03Debt to equity was 2.02 on the figures at the source.
- 04The PAT margin was low at 3.86%.
- 05Total income slipped from Rs 281.61 crore in FY2024 to Rs 276.09 crore in FY2025.
- 06Return on net worth was 10.89%, against a P/E of 46.59.
- 07Promoters held 85.6% before the issue and held 63.56% after it.
Three years of numbers
All figures in ₹ crore, as reported in the Amanta Healthcare offer document.
| Metric | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 381.76 | 352.12 | 374.06 |
| Total Income | 276.09 | 281.61 | 262.70 |
| Profit After Tax | 10.50 | 3.63 | -2.11 |
| EBITDA | 61.05 | 58.76 | 56.31 |
| NET Worth | 96.39 | 66.29 | 62.88 |
| Reserves and Surplus | 67.56 | 39.46 | 36.05 |
| Total Borrowing | 195.00 | 205.23 | 215.66 |
See how this IPO compares — view listing performance of all mainboard IPOs.
Valuation & key ratios
Ratios are for the latest full financial year reported in the Amanta Healthcare RHP. EPS and P/E are post-issue — the table below carries the pre-issue comparison.
Amanta Healthcare IPO Valuation
How the issue prices the company before and after the fresh shares are created.
| Valuation Metric | Pre-Issue | Post-Issue |
|---|---|---|
| EPS (₹) | ₹3.64 | ₹2.70 |
| P/E Ratio (x) | 34.59 | 46.59 |
| Market Cap at Offer Price (₹ Cr) | ₹363.46 | ₹490.00 |
Pre-issue figures use the shareholding reported in the RHP; post-issue figures use the shareholding once the fresh issue has created new shares. The two differ because of that dilution and because post-issue earnings per share are often annualised, so the change can run in either direction. Market capitalisation is calculated at the ₹126 offer price. Compare the post-issue P/E against listed peers before deciding — a premium there is growth you are paying for in advance.
Where the money goes
₹125.99 Cr of the issue is earmarked to named objects.
Amanta Healthcare IPO Anchor Investors
6 anchor investors across 6 fund houses committed ₹37.80 Cr a day before the issue opened.
| Anchor Investor | Fund House | Shares | Amount (₹ Cr) | % of Anchor Book |
|---|---|---|---|---|
| Bandhan Small Cap Fund | Bandhan Mutual Fund | 793,730 | 10.00 | 26.46% |
| Sanshi Fund-1 | Sanshi | 595,010 | 7.50 | 19.83% |
| Perpetuity Health To Wealth (H2W) Rising Fund | Perpetuity Health To | 420,665 | 5.30 | 14.02% |
| Aarth Growth Fund | Aarth | 396,865 | 5.00 | 13.23% |
| Sunrise Investment Trust-Sunrise Investment Opportunities Fund | Sunrise | 396,865 | 5.00 | 13.23% |
| Finavenue Capital Trust-Finavenue Growth Fund | Finavenue | 396,865 | 5.00 | 13.23% |
| Total anchor allocation | 37.80 | |||
Anchor investors bid a day before the issue opens and are locked in after allotment, so a book weighted towards domestic mutual funds is generally read as a stronger signal than one filled by short-horizon funds. Browse every anchor investor scheme or fund house we track.
About the company
The range includes IV fluids, diluents, ophthalmic solutions and respiratory care products. In medical devices it offers irrigation solutions, first-aid products and eye lubricants.
The company sells through three business units: national sales, international sales and product partnering.
The IPO was a fresh issue of Rs 126 crore. Rs 70.00 crore and Rs 30.13 crore were planned for two civil construction and machinery projects.
Interested in this IPO? Check the live subscription status or browse all upcoming mainboard IPOs.
The bankers & the filings
Who is running the book, and the documents this page is built from.
Amanta Healthcare IPO Documents
Read the filings this page is built from.
Lead Manager Track Record
How the book-running lead managers on this issue have priced their past IPOs, measured on listing day.
Beeline Capital Advisors Pvt. Ltd.
8 issues handled (4 mainboard, 4 SME)Best listing: Kratikal Tech (+42.2%). Weakest: Modern Diagnostic & Research Centre (0.0%).
Listing gain compares the listing-day opening price with the issue price, using the IPOs on IPO Guru that this lead manager has taken to market. A strong record reflects how the banker has priced past issues — it is not a forecast for this one. See every issue they have handled on the lead managers page.
Company contact
Frequently asked
What is the GMP of Amanta Healthcare?
The current Grey Market Premium is ₹8, or 6% over the issue price.
What is the Amanta Healthcare IPO price band?
₹120 to ₹126, on a face value of ₹10.
When is the allotment?
The basis of allotment is 4 September 2025, with listing on 9 September 2025.
How do I check allotment status?
On the IPO Guru allotment page or on the registrar's site — MUFG Intime India Private Limited.
Every number here traces back to a filing.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Every number on this page is sourced from the RHP, BSE & NSE.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
